Agenda for Urosilesiana XXIX

Friday 16.10.2026

16:50 Opening of the Conference

Michał Wróbel, Marcin Życzkowski

17:00 – 19:00 Session I: Systemic Treatment in Urology

Chairs: Tomasz Szydełko, Marcin Życzkowski, Bartosz Małkiewicz, Paweł Rajwa.

1. Tomasz Szydełko, Enzalutamide – efficacy and tolerability that define its place in the guidelines. Sponsored lecture
2. Bartosz Małkiewicz, Modern standards in the treatment of advanced prostate cancer. Sponsored lecture
3. Paweł Rajwa, Prostate cancer – current clinical challenges. Sponsored lecture
4. Bartosz Małkiewicz, From dogma to precision: HERO and REVOLUTION — a new approach to ADT in 2026. Sponsored lecture
5. Wojciech Krajewski, Phase III clinical trial EV-302. Sponsored lecture
6. Q&A and discussion

Saturday, 17.10.2026

8:40 – 10:20 Session II: Adrenal Tumors and Robot-Assisted Procedures

Chairs: Tomasz Szydełko, Bartosz Małkiewicz, Michał Wróbel, Tomasz Tomkalski

1. Tomasz Tomkalski, When to operate and how to prepare a patient with an adrenal tumor.
2. Sebastian Bobowski, Wojciech Tomkalski, Who did we operate on? Analysis of histopathological results from adrenalectomies.
3. Jakub Ryszawy, Laparoscopic surgery of a 16 cm adrenal tumor.
4. Aleksander Radecki, Robotic RPLND in testicular tumors – a minimally invasive alternative to open surgery (Video).
5. Mikołaj Kisiała, Functional and oncological outcomes – general characterization of the first 750 RARP procedures.
6. Patryk Patrzałek, Impact of surgeon experience on perioperative outcomes of robotic radical prostatectomy — an analysis of 750 procedures.
7. Q&A and discussion

10:20 – 10:25 Break

10:25 – 11:55 Session III: Prostate and Bladder Cancer

Chairs: Romuald Zdrojowy, Anna Kołodziej, Marcin Życzkowski

1. Paweł Rajwa, Stockholm3 in prostate cancer diagnostics.
2. Patryk Banaś, Digital rectal examination in the age of magnetic resonance imaging.
3. Paweł Sybila, Concordance between prostate biopsy results and final histopathological outcomes after radical prostatectomy.
4. Piotr Krzystyniak, Prostate cancer in the era of AI — can an algorithm support mpMRI evaluation?
5. Łukasz Nowak, Modern focal therapy methods for prostate cancer — an overview of current therapeutic options.
6. Adam Gurwin, PET-PSMA — a great test, but…
7. Bartosz Bujała, Comparison of transrectal vs. transperineal fusion prostate biopsy outcomes at the Department of Urology in Zabrze.
8. Klaudia Korlacka, PD-L1 in urothelial bladder cancer: biological significance, interpretative limitations, and its role in treatment eligibility.
9. Q&A and discussion

11:55 – 12:00 Break

12:00 – 13:30 Session IV: Endoscopy and Urolithiasis

Chairs: Wojciech Krajewski, Piotr Bryniarski, Jakub Ryszawy

1. Wojciech Krajewski, Intraluminal adjuvant treatment in UTUC.
2. Jan Łaszkiewicz, When can we omit anesthesiologist assistance? TULA and URS under local anesthesia.
3. Adam Chełmoński, Percutaneous CT-guided renal tumor biopsy: feasibility, diagnostic yield, and safety profile.
4. Jakub Hobot, Antegrade URS as a treatment strategy for challenging cases in endourology.
5. Michał Iwanicki, Assessment of the post-cryoablation renal tumor bed on CT and MRI.
6. Piotr Bryniarski, Loading/provocation tests in the metabolic evaluation of urolithiasis.
7. Maciej Hobot, Laser lithotripsy strategies during RIRS: dusting vs. fragmentation — impact on SFR and application of the FANS technique.
8. Wojciech Tomczak, Prevention of recurrent urinary tract stone disease: guidelines vs. clinical practice.
9. Q&A and discussion

13:30 – 14:00 Lunch Break

14:00 – 15:20 Session V: Complications

Chairs: Michał Wróbel, Adrian Czekaj, Arnold Karbowski

1. Sebastian Fedorowicz, Hematuria in the ER: urological complications?
2. Dariusz Salamon, Long-term urological sequelae of a popular gynecological procedure.
3. Gracjan Sitarek, Superselective renal artery embolization in the treatment of iatrogenic hemorrhagic complications after urological procedures — a clinical case series analysis from the perspective of the “bleeding phenotype.”
4. Adrian Czekaj, Hydraulic penile prosthesis — how to reduce the risk of infectious complications?
5. Artur Pietrusa, Impact of electrosurgical energy modality on post-TURBT complications.
6. Q&A and discussion

Sunday, 18.10.2026

8:50 – 10:50 Session VI: Care of the Urological Patient

Chairs: Edyta Chamioło-Sołtysik, Zenona Jabłońska, Beata Gancarz

1. Aleksandra Kozłowska, Barriers and challenges in delivering person-centered care — an analysis of staff attitudes.
2. Ewa Stypułkowska, Arleta Zarzeczna, Individualized approach to the ostomy patient — the key to success in ostomy care.
3. Paulina Masłyk, Joanna Perdek, Principles of perioperative prehabilitation in the urology ward.
4. Beata Gancarz, Marcelina Wągieł, Jolanta Kaczerewska, Lidia Kapij Łucarz, Can a nurse predict post-urological surgery complications? Frailty as a new vital sign.
5. Q&A and discussion

10:50 – 10:55 Break

10:55 – 11:55 Session VII: Testicular and Penile Diseases

Chairs: Zenona Jabłońska, Michał Wróbel, Paweł Piotrów

1. Adrian Poterek, Penile cancer — organ-sparing treatment: institutional experience.
2. Mateusz Piątek, Management of priapism — institutional experience.
3. Joanna Chorbińska, Bilateral testicular tumors.
4. Paweł Piotrów, Vasovasostomy — why, when and how.

11:55 – 12:00 Break

12:00 – 13:30 Session VIII: Varia

Chairs: Andrzej Borzhijevsky, Krzysztof Ratajczyk, Radosław Piszczek

1. Michał Tabor, Tumor in a transplanted kidney — a case report.
2. Jakub Mikszta, Laparoscopic NSS of a large renal mass in a 30-year-old female patient.
3. Artur Pietrusa, TURBT surgical methodology between 2022 and 2026: single-center experience.
4. Artur Pietrusa, Comparison of perioperative outcomes between laparoscopic and robotic prostatectomy in prostate cancer patients.
5. Artur Pietrusa, Factors associated with length of hospital stay following surgical treatment for prostate cancer.
6. Michał Pułtorak, Technical aspects of transurethral access during TURBT in a morbidly obese patient — case report and literature review.
7. Adam Lubas, Tomasz Karolczyk, Prostatic leiomyosarcoma.
8. Q&A and discussion

13:30 Closing of the Conference